4 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow SENS-401: new trials by email Literature Review of SENS-401 trials Research Report on SENS-401
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease SENS-401 (R-Azasetron Besylate) - Hearing Loss Ototoxic | Phase 2 | Completed | Sensorion | 48 | 2022-12-30 | 2026-07-02 |
| Evaluation of the Presence of SENS-401 in the Perilymph SENS-401 (R-Azasetron Besylate) - Hearing Loss | Phase 2 | Completed | Sensorion | 28 | 2022-08-10 | 2025-04-23 |
| Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss SENS-401, Placebo Oral Tablet - Severe Sudden Sensorineural Hearing Loss | Phase 2 / Phase 3 | Completed | Sensorion | 115 | 2019-02-15 | 2023-03-01 |
| A Study of SENS 401 in Healthy Subjects SENS-401, Placebo - Inner Ear Disease | Phase 1 | Completed | Simbec Research | 36 | 2016-10-21 | 2019-04-08 |
Hearing Loss (1) · Hearing Loss, Sudden (1) · Labyrinth Diseases (1)
Sensorion (3) · Simbec Research (1)
France (3) · United Kingdom (2) · Australia (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Germany (1) · Israel (1) · Serbia (1) · Slovakia (1) · Turkey (Türkiye) (1)
Robert Adams, MBBS (1) · Stephen O'Leary, MD (1)